These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35411535)

  • 21. Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California's prescription drug monitoring program.
    Castillo-Carniglia A; González-Santa Cruz A; Cerdá M; Delcher C; Shev AB; Wintemute GJ; Henry SG
    Drug Alcohol Depend; 2021 Jan; 218():108405. PubMed ID: 33234299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of a Mandatory Prescription Drug Monitoring Program Check on Emergency Department Opioid Prescribing Rates.
    Watson CJ; Ganetsky M; Burke RC; Dizitzer Y; Leventhal EL; Boyle KL
    J Med Toxicol; 2021 Jul; 17(3):265-270. PubMed ID: 33821434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
    Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
    JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of a Statewide Mandatory Prescription Drug Monitoring Program on Opioid Prescribing by Emergency Medicine Providers Across 15 Hospitals in a Single Health System.
    Suffoletto B; Lynch M; Pacella CB; Yealy DM; Callaway CW
    J Pain; 2018 Apr; 19(4):430-438. PubMed ID: 29241835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping prescription drug monitoring program data to self-report measures of non-medical prescription opioid use in community pharmacy settings.
    Charron E; Brooks JH; Peterson KT; Akinwolere OG; Winhusen T; Cochran G
    Res Social Adm Pharm; 2023 Aug; 19(8):1171-1177. PubMed ID: 37142474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mandatory use of prescription drug monitoring program and benzodiazepine prescribing among U.S. Medicaid enrollees.
    Liang D; Guo H; Shi Y
    Subst Abus; 2021; 42(3):294-301. PubMed ID: 31697195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variations in prescription drug monitoring program use by prescriber specialty.
    Sun BC; Lupulescu-Mann N; Charlesworth CJ; Kim H; Hartung DM; Deyo RA; John McConnell K
    J Subst Abuse Treat; 2018 Nov; 94():35-40. PubMed ID: 30243415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid Prescribing After Implementation of Single Click Access to a State Prescription Drug Monitoring Program Database in a Health System's Electronic Health Record.
    Weiner SG; Kobayashi K; Reynolds J; Chan K; Kelly R; Wakeman S; Reddy P; Young LD
    Pain Med; 2021 Oct; 22(10):2218-2223. PubMed ID: 33561288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescription drug monitoring programs use mandates and prescription stimulant and depressant quantities.
    Gunadi C; Shi Y
    BMC Public Health; 2023 Jul; 23(1):1326. PubMed ID: 37434122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decrease in Urologic Discharge Opioid Prescribing after Mandatory Query of Statewide Prescription Drug Monitoring Program.
    Myrga JM; Macleod LC; Bandari J; Jacobs BL; Davies BJ
    Urology; 2020 May; 139():84-89. PubMed ID: 32061826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic.
    Stein BD; Sheng F; Taylor EA; Dick AW; Sorbero M; Pacula RL
    Drug Alcohol Depend; 2022 Feb; 231():109232. PubMed ID: 35007956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in opioid agonist treatment initiation among people prescribed opioids for pain following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis.
    Picco L; Xia T; Bell JS; Pearce C; Buchbinder R; Lubman DI; Nielsen S
    Drug Alcohol Rev; 2023 Nov; 42(7):1639-1646. PubMed ID: 37798947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Online Prescription Drug Monitoring on Opioid Prescription Habits After Elective Single-level Lumbar Fusion.
    Siegel N; Lambrechts MJ; Minetos P; Karamian BA; Nourie B; Curran J; Wang J; Canseco JA; Woods BI; Kaye D; Hilibrand AS; Kepler CK; Vaccaro AR; Schroeder GD
    J Am Acad Orthop Surg; 2022 Nov; 30(21):e1411-e1418. PubMed ID: 35947832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.
    Brown WC; Whitted K
    J Dr Nurs Pract; 2020 Jul; 13(2):142-147. PubMed ID: 32817503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy and validity of reported opioid prescription days' supply.
    Miracle DK; Slavova S; Brown JR; Dasgupta N; Harris S; Freeman PR
    Pharmacoepidemiol Drug Saf; 2022 Dec; 31(12):1253-1261. PubMed ID: 36053913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impacts of prescription drug monitoring program policy changes and county opioid safety coalitions on prescribing and overdose outcomes in California, 2015-2018.
    Henry SG; Shev AB; Crow D; Stewart SL; Wintemute GJ; Fenlon C; Wirtz SJ
    Prev Med; 2021 Dec; 153():106861. PubMed ID: 34687731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
    Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
    Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protocol: mixed-methods study to evaluate implementation, enforcement, and outcomes of U.S. state laws intended to curb high-risk opioid prescribing.
    McGinty EE; Stuart EA; Caleb Alexander G; Barry CL; Bicket MC; Rutkow L
    Implement Sci; 2018 Feb; 13(1):37. PubMed ID: 29482599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
    Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
    Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a legislative mandate on opioid prescribing for back pain in the emergency department.
    Khobrani M; Perona S; Patanwala AE
    Am J Emerg Med; 2019 Nov; 37(11):2035-2038. PubMed ID: 30824275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.